WS
QNTM

Wedbush Securities’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Wedbush Securities’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-989
Closed -$164K – 989
2020
Q3 		$164K Buy
989
+607
+159% +$126K 0.02% 786
2020
Q2 		$95K Buy
+382
New +$89.5K 0.01% 863

Other funds holding QNTM

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RPC
Rossmore Private Capital Glastonbury, Connecticut $1.14B AUM 23.53% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Wedbush Securities's QNTM Position: Q4 2020 in Review

Wedbush Securities sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q4 2020, closing a stake of 989 shares — an estimated $164K sold.

Wedbush Securities first reported a position in QNTM in Q2 2020 and held it in 2 quarters. The position peaked at $164K in Q3 2020. 12 funds tracked by Wall St. Rank hold QNTM as of Q4 2020.

  • Wedbush Securities reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q4 2020 after selling out during the quarter.
  • Wedbush Securities sold 989 Quantum Biopharma Class B Subordinate Voting Shares shares in Q4 2020, an estimated $164K.
  • Wedbush Securities first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q2 2020 and held it in 2 quarters.
  • Wedbush Securities's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $164K in Q3 2020.
  • 12 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q4 2020.

Based on Wedbush Securities's 13F filing for Q4 2020, filed 16 Feb 2021.